diabetes

November 3, 2020

New treatment for a rare obesity

Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.

By Bill Snyder
October 5, 2020

Clue to diabetic kidney disease

Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication.

By Sarah E. Glass
July 28, 2020

Study challenges idea that lower BMI shields smokers from fat-associated health risks

While some smokers might rationalize continuing to smoke because of the lower weight often associated with the habit, Vanderbilt University Medical Center investigators have determined that even with a lower body mass index (BMI), smokers have a higher risk of depositing fat in and around organs and tissues compared to those who never smoked.

By Jill Clendening
July 9, 2020

Keeping beta cells “fit”

Vanderbilt cell biologists are defining the factors that help beta cells in the pancreas stay healthy, secrete insulin and prevent diabetes initiation and progression.

By Leigh MacMillan
June 11, 2020

Staff Nurses of the Year named

Rosamund Gabrielson Staff Nurse of the Year recipients were announced representing the four entities of VUMC

By Matt Batcheldor
Fourth-year VUSM student Emily Long assists Paul Epstein, MD, as he conducts telehealth visits with patients of the Vanderbilt Eskind Diabetes Clinic.
April 23, 2020

VUSM students help patients, clinicians with telehealth

When in-person visits to Vanderbilt Eskind Diabetes Clinic needed to be quickly converted to telehealth appointments in response to COVID-19, a novel solution was hatched to bring both clinicians and patients up to speed on videoconferencing.

By Jill Clendening
March 19, 2020

Race, hormones and diabetes risk

Variation in the levels of hormones called natriuretic peptides may contribute to racial differences in susceptibility to diabetes, suggesting that this hormone system may be a target for reducing risk of the disease.
By VUMC News and Communications
February 20, 2020

Post-transplant diabetes may be reversible: study

Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.
By Bill Snyder
January 16, 2020

Pediatric diabetes, palliative care focus of new Friends of Children’s Hospital gift

Friends of Monroe Carell Jr. Children’s Hospital at Vanderbilt, a volunteer organization, recently committed $1 million over the next three years to be split between two crucial pediatric programs: diabetes and palliative care.
By Nancy Humphrey
December 18, 2019

Telehealth grant boosts diabetes prevention efforts

Vanderbilt’s Diabetes Prevention Program (DPP) has demonstrated its effectiveness at helping employees lose weight as a means of preventing Type 2 diabetes and has received a five-year grant from the National Institutes of Health (NIH) to expand the program using telehealth.
By Wayne Wood
December 12, 2019

Diabetes Day shines spotlight on crucial research

Research in the fields of diabetes, endocrinology and metabolism were highlighted recently during the annual Diabetes Day at the Vanderbilt Student Life Center.
By Jill Clendening
December 4, 2019

Genetic screen in worms reveals critical step in insulin synthesis

The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.
By Leigh MacMillan
November 7, 2019

Griffith honored for her contributions to telehealth initiatives

Michelle Griffith, MD, recently received an award for her work building networks for and advocacy of telehealth.
By Jill Clendening
1 … 4 5 6 7 8 … 18